I'm not mad, I'm disappointed. This product did not work at all. It didn't even feel like it was just a caffeine pill (usually what supplements that don't work are actually made of). It literally does nothing. In hindsight, I feel like I did when I was a kid and ordered $4.50 X-ray sunglasses from the back of a comic book. Deep down knew it was too good to be true, but secretly I hoped it would work. Shame on me for getting sucked into a bunch of hype.
The problems with our mental functions begin if the blood flow to the brain cells is disrupted regardless of the reasons. There are countless capillaries in the head, which supply the brain with essential nutrients and oxygen. If the blood doesn’t get to these capillaries, your optimal mental performance is compromised. Here’s a term worth remembering – hypoperfusion. If you’re suffering from hypoperfusion, then this means you are having problems with the blood flow to your brain. Here’s a quick overview of the factors that most commonly cause hypoperfusion:
Following up on the promising but unrandomized pilot, I began randomizing my LLLT usage since I worried that more productive days were causing use rather than vice-versa. I began on 2 August 2014, and the last day was 3 March 2015 (n=167); this was twice the sample size I thought I needed, and I stopped, as before, as part of cleaning up (I wanted to know whether to get rid of it or not). The procedure was simple: by noon, I flipped a bit and either did or did not use my LED device; if I was distracted or didn’t get around to randomization by noon, I skipped the day. This was an unblinded experiment because finding a randomized on/off switch is tricky/expensive and it was easier to just start the experiment already. The question is simple too: controlling for the simultaneous blind magnesium experiment & my rare nicotine use (I did not use modafinil during this period or anything else I expect to have major influence), is the pilot correlation of d=0.455 on my daily self-ratings borne out by the experiment?
The main concern with pharmaceutical drugs is adverse effects, which also apply to nootropics with undefined effects. Long-term safety evidence is typically unavailable for nootropics. Racetams — piracetam and other compounds that are structurally related to piracetam — have few serious adverse effects and low toxicity, but there is little evidence that they enhance cognition in people having no cognitive impairments.